Rezolute, Inc. - COMMON STOCK (RZLT) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
RZLT on Nasdaq
Shares outstanding
92,222,720
Price per share
$2.36
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
86,920,142
Total reported value
$817,052,884
% of total 13F portfolios
0.01%
Share change
+8,943,542
Value change
+$108,361,490
Number of holders
115
Price from insider filings
$2.36
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Rezolute, Inc. - COMMON STOCK (RZLT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $146,288,898 15,302,186 RA Capital Healthcare Fund, L.P. 11 Dec 2025
Opaleye Management Inc. 5.3% $46,967,324 4,912,900 Opaleye Management Inc. 12 Dec 2025
BlackRock, Inc. 5.4% $45,886,185 4,881,509 BlackRock, Inc. 30 Sep 2025
Invus Global Management, LLC 5.4% $34,090,000 4,870,000 Raymond Debbane 18 Sep 2025
Nantahala Capital Management, LLC 4.9% -41% $11,317,609 -$8,350,591 2,857,982 -42% Nantahala Capital Management, LLC 31 Dec 2024
FMR LLC 2.5% -83% $5,379,582 -$24,514,368 2,305,568 -82% FMR LLC 31 Dec 2025

As of 30 Sep 2025, 115 institutional investors reported holding 86,920,142 shares of Rezolute, Inc. - COMMON STOCK (RZLT). This represents 94% of the company’s total 92,222,720 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Rezolute, Inc. - COMMON STOCK (RZLT) together control 84% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FEDERATED HERMES, INC. 15% 14,034,712 0% 0.23% $131,926,293
FMR LLC 14% 12,764,233 -0.37% 0.01% $119,983,791
BlackRock, Inc. 5.4% 5,004,436 +23% 0% $47,041,697
Siren, L.L.C. 5.3% 4,870,000 1.8% $45,778,000
VANGUARD GROUP INC 4.8% 4,410,082 +9.6% 0% $41,454,771
Blackstone Inc. 3.3% 3,023,899 -15% 0.12% $28,424,651
MANGROVE PARTNERS IM, LLC 3.1% 2,882,149 +25% 2% $27,092,201
MARSHALL WACE, LLP 3% 2,728,315 -5.5% 0.03% $25,646,160
UBS Group AG 2.9% 2,695,978 -11% 0% $25,342,193
GREAT POINT PARTNERS LLC 2.7% 2,451,809 -19% 9.6% $23,047,005
Vivo Capital, LLC 2.3% 2,112,432 0% 1.6% $19,856,861
Affinity Asset Advisors, LLC 2.3% 2,100,000 -4.5% 1.8% $19,740,000
STATE STREET CORP 2.3% 2,091,476 +152% 0% $19,659,874
Integral Health Asset Management, LLC 2.2% 2,000,000 +11% 1.4% $18,800,000
CAXTON CORP 2.2% 1,986,818 +24% 82% $18,676,089
GEODE CAPITAL MANAGEMENT, LLC 2% 1,847,384 +8% 0% $17,369,547
Balyasny Asset Management L.P. 2% 1,822,728 0.03% $17,133,643
Rosalind Advisors, Inc. 2% 1,807,202 +3.8% 6.2% $16,987,698
BANK OF AMERICA CORP /DE/ 1.4% 1,284,962 +1579% 0% $12,078,642
Point72 Asset Management, L.P. 1.3% 1,157,410 +447% 0.02% $10,879,651
Woodline Partners LP 1% 938,844 -51% 0.04% $8,825,134
STEMPOINT CAPITAL LP 1% 917,630 +42% 1.7% $8,625,722
Opaleye Management Inc. 0.98% 903,442 0% 1.2% $8,492,355
22NW, LP 0.89% 820,653 4% $7,714,138
ADAR1 Capital Management, LLC 0.88% 815,975 -18% 0.77% $7,670,165

Institutional Holders of Rezolute, Inc. - COMMON STOCK (RZLT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 75,772 $178,674 -$375,926 $2.36 3
2025 Q3 86,920,142 $817,052,884 +$108,361,490 $9.40 115
2025 Q2 77,913,169 $347,492,575 +$151,537,051 $4.46 91
2025 Q1 45,040,344 $130,615,009 -$811,015 $2.90 76
2024 Q4 43,207,187 $211,713,139 +$30,093,702 $4.90 71
2024 Q3 38,544,894 $186,942,117 -$3,938,820 $4.85 59
2024 Q2 39,525,913 $169,961,526 +$54,178,980 $4.30 51
2024 Q1 27,042,621 $68,962,251 +$246,860 $2.55 33
2023 Q4 28,952,301 $28,740,703 +$4,794,203 $0.99 31
2023 Q3 23,889,501 $31,534,322 -$458,985 $1.32 29
2023 Q2 24,223,878 $47,962,915 +$49,684 $1.98 28
2023 Q1 24,226,408 $46,514,454 -$475,670 $1.92 31
2022 Q4 24,450,852 $50,611,801 -$822,266 $2.07 34
2022 Q3 24,446,950 $67,002,000 -$497,915 $2.74 30
2022 Q2 24,538,369 $79,207,000 +$56,346,030 $3.23 33
2022 Q1 7,085,710 $23,951,000 -$2,289,045 $3.38 19
2021 Q4 7,529,707 $35,989,000 +$22,778,341 $4.78 21
2021 Q3 2,373,215 $17,647,000 +$1,206,770 $7.48 13
2021 Q2 2,211,492 $31,558,000 -$1,377,636 $14.27 11
2021 Q1 2,477,026 $17,487,000 -$208,256 $7.06 10
2020 Q4 2,506,346 $30,230,000 +$30,230,000 $11.99 7